Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um weitere News abzurufen!
      OK      
x
Impact News +++ Macy′s Q3 Adjusted EPS USD 0.04 (Reuters EN) +++ MACYS Aktie -13,03%

APPLIED THERAPEUTICS Aktie

 >Aktienkurs 
1.159 EUR    +1.2%    (Tradegate)
Ask: 1.153 EUR / 2600 Stück
Bid: 1.12 EUR / 2680 Stück
Tagesumsatz: 7697 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>Performance
1 Woche: -12,4%
1 Monat: -88,3%
3 Monate: -75,3%
6 Monate: -75,6%
1 Jahr: -55,6%
laufendes Jahr: -59,5%
>APPLIED THERAPEUTICS Aktie
Name:  APPLIED THERAPEUTICS
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US03828A1016 / A2PHHB
Symbol/ Ticker:  2UV (Frankfurt) / APLT (NASDAQ)
Kürzel:  FRA:2UV, ETR:2UV, 2UV:GR, NASDAQ:APLT
Index:  -
Webseite:  https://www.appliedtherap..
Marktkapitalisierung:  140.7 Mio. EUR
Umsatz:  -0.2 Mio. EUR
EBITDA:  -87.64 Mio. EUR
Gewinn je Aktie:  -1.273 EUR
Schulden:  1.87 Mio. EUR
Liquide Mittel:  93.9 Mio. EUR
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  53.53 / 24.56 / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  APPLIED THERAPEUTICS
Letzte Datenerhebung:  10.12.24
>Eigentümer
Aktien: 116.36 Mio. St.
f.h. Aktien: 84.77 Mio. St.
Insider Eigner: 5.24%
Instit. Eigner: 103.26%
Leerverk. Aktien: 13.01%
>Peer Group

 
03.12.24 - 00:44
Applied Therapeutics says it received FDA′s warning letter for genetic disease drug study (Reuters EN)
 
UPDATE 1-Applied Therapeutics says it received FDA's warning letter for genetic disease drug study Adds background on drug in paragraphs 2 and 3, details in paragraphs 4 to 7 Dec 2 (Reuters) - Applied Therapeutics APLT.O said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after the U.S. health regulator declined to approve the treatment last week....
29.11.24 - 19:55
S&P 500, Dow close at record highs on tech, retail in focus (Reuters EN)
 
US STOCKS-S&P 500, Dow close at record highs on tech, retail in focus Nvidia leads tech stocks, retail stocks edge up Applied Therapeutics plummets after FDA declines drug approval Retail stocks up on Black Friday Indexes up; Dow 0.42%, S&P 500 0.56%, Nasdaq 0.83% Updates with closing prices, volumes By Saeed Azhar, Johann M Cherian and Purvi Agarwal Nov 29 (Reuters) - The S&P 500 and Dow Jones Industrial Average notched record closing highs in a shortened Black Friday session, lifted by technol...
29.11.24 - 19:20
S&P 500, Dow close at record highs on tech (Reuters EN)
 
US STOCKS-S&P 500, Dow close at record highs on tech S&P 500 hits record intraday high Nvidia leads tech stocks, retail stocks edge up Applied Therapeutics plummets after FDA declines drug approval Updates to early market close By Saeed Azhar, Johann M Cherian and Purvi Agarwal Nov 29 (Reuters) - The S&P 500 and Dow Jones Industrial Average notched record closing highs in a shortened Black Friday session, lifted by select technology stocks, while retail was in focus as the holiday shopping seaso...
29.11.24 - 18:03
S&P 500 hits record high as major indexes rise on tech, retail stocks (Reuters EN)
 
US STOCKS-S&P 500 hits record high as major indexes rise on tech, retail stocks S&P 500 hits record intraday high Nvidia leads tech stocks, retail stocks edge up Applied Therapeutics plummets after FDA declines drug approval Markets to close at 1:00 p.m. ET Indexes up: Dow 0.45%, S&P 500 0.51%, Nasdaq 0.68% Updates to midday trading By Johann M Cherian, Purvi Agarwal and Saeed Azhar Nov 29 (Reuters) - The S&P 500 index hit a record high as Wall Street's main indexes rose in a shortened Black Fri...
29.11.24 - 16:56
Wall St inches up; Black Friday sales, retailers in focus (Reuters EN)
 
US STOCKS-Wall St inches up; Black Friday sales, retailers in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Retail stocks edge up Applied Therapeutics plummets after FDA declines drug approval Markets to close at 1:00 p.m. ET Indexes up: Dow 0.31%, S&P 500 0.23%, Nasdaq 0.25% Updates at market open By Johann M Cherian and Purvi Agarwal Nov 29 (Reuters) - Wall Street's main indexes opened slightly higher in a shortened Black Frid...
29.11.24 - 16:00
Applied Therapeutics stock craters 75% on FDA setback (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.11.24 - 15:21
Wall St set for higher open in shorter Black Friday session (Reuters EN)
 
US STOCKS-Wall St set for higher open in shorter Black Friday session For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Retailers edge up ahead of Black Friday trading Applied Therapeutics plummets after FDA declines drug approval Markets to close at 1:00 p.m. ET Futures up: Dow 0.19%, S&P 500 0.15%, Nasdaq 0.09% Updates before market open By Johann M Cherian and Purvi Agarwal Nov 29 (Reuters) - U.S....
29.11.24 - 15:12
HotStocks USA: Applied Therapeutics bricht um über 74 % ein (Stock3)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
29.11.24 - 14:58
US-Handel: Nach Thanksgiving Wall Street höher erwartet - MicroStrategy und Applied Therapeutics im Fokus (Der Aktionaer)
 
Nach der Handelspause am gestrigen Donnerstag wegen Thanksgiving dürften die US-Aktienmärkte heute mit moderaten Gewinnen eröffnen. Allerdings schließen die Börsen wegen des langen Erntedank-Wochenendes in den USA bereits drei Stunden früher....
29.11.24 - 13:44
Futures gain before shortened Black Friday session (Reuters EN)
 
US STOCKS-Futures gain before shortened Black Friday session For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Retailers edge up ahead of Black Friday trading session Applied Therapeutics plummets after FDA declines drug approval Futures up: Dow 0.38%, S&P 500 0.30%, Nasdaq 0.33% Updates with prices By Johann M Cherian and Purvi Agarwal Nov 29 (Reuters) - U.S....
29.11.24 - 13:13
U.S. STOCKS Applied Therapeutics, iShares MSCI (Reuters EN)
 
BUZZ-U.S. STOCKS ON THE MOVE-Applied Therapeutics, iShares MSCI Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures rose ahead of a truncated trading session on Friday, with Wall Street's main indexes on track for monthly gains as the holiday shopping season kicked off on a brisk note and investor attention shifted to retail stocks....
29.11.24 - 12:44
U.S. Applied Therapeutics, Brown-Forman, Ulta Beauty (Reuters EN)
 
U.S. RESEARCH ROUNDUP-Applied Therapeutics, Brown-Forman, Ulta Beauty Nov 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Therapeutics, Brown-Forman and Ulta Beauty on Friday. HIGHLIGHTS * Applied Therapeutics Inc APLT.O : RBC cuts to sector perform from outperform * Brown-Forman BFb.N : Barclays cuts target price to $49 from $53 * Descartes Systems Group Inc DSGX.O : RBC raises target price to $133 from $...
28.11.24 - 17:18
APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA (Zacks)
 
Applied Therapeutics stock plummets 77% after the FDA issues a CRL for the company's NDA seeking approval for govorestat to treat classic galactosemia....
27.11.24 - 23:09
Applied Therapeutics plummets after FDA declines to approve genetic disease drug (Reuters EN)
 
BUZZ-Applied Therapeutics plummets after FDA declines to approve genetic disease drug ** Shares of Applied Therapeutics APLT.O fall 80.3% to $1.70 after the bell ** Co mpany says the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic metabolic disease ** The FDA's letter to the company said the marketing application for the...
27.11.24 - 22:56
US FDA declines to approve Applied Therapeutics′ genetic disease drug (Reuters EN)
 
UPDATE 2-US FDA declines to approve Applied Therapeutics' genetic disease drug Adds shares in paragraph 2, background in paragraphs 6-10 Nov 27 (Reuters) - Applied Therapeutics APLT.O said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic metabolic disease, casting a cloud over the company's hopes for its first commercial product....
27.11.24 - 22:45
Applied Therapeutics drops 16% following Complete Response Letter (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.11.24 - 22:12
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia (GlobeNewswire EN)
 
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia....
07.11.24 - 15:39
Applied Therapeutics GAAP EPS of -$0.48, revenue of $0.12M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.24 - 13:03
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference (GlobeNewswire EN)
 
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present at the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024, at 7:15 a.m. PT in Rancho Palos Verdes, California....
29.10.24 - 18:33
Applied Therapeutics (APLT) Upgraded to Buy: Here′s What You Should Know (Zacks)
 
Applied Therapeutics (APLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
>Zitat des Tages: Höre, mein Sohn, und sei weise. Lenk dein Herz auf geraden Weg! Gesell dich nicht zu den Weinsäufern, zu solchen, die im Fleischgenuß schlemmen; denn Säufer und Schlemmer werden arm. - Altes Testament: Spruch
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick! neu